Zobrazeno 1 - 10
of 65
pro vyhledávání: '"D. A Bakulin"'
Autor:
D. V. Kurkin, E. I. Morkovin, D. A. Bakulin, A. V. Zaborovsky, I. E. Makarenko, R. V. Drai, A. G. Solodovnikov, V. I. Petrov, K. N. Koryanova, N. A. Lycheva, S. A. Voskresensky, A. V. Strygin, Yu. A. Kolosov, Yu. V. Gorbunova, O. V. Ivanova
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 5, Pp 384-398 (2024)
The aim of the work was to conduct an analysis of the current state and current trends in the approval of drugs, as well as some aspects of the methodology for their development based on biological molecules and registration.Materials and methods. Th
Externí odkaz:
https://doaj.org/article/2dc8114950e748bbbd40243f3b14fe6b
Autor:
D. V. Kurkin, D. A. Bakulin, E. I. Morkovin, V. I. Petrov, A. V. Strygin, K. N. Koryanova, Yu. V. Gorbunova, Yu. A. Kolosov, O. V. Ivanova, E. V. Pavlova, M. A. Dzhavakhyan, A. V. Zaborovsky, V. B. Saparova, I. E. Makarenko, R. I. Drai, A. N. Chumachenko
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 4, Pp 347-380 (2024)
Modern approaches to the treatment of type 2 diabetes mellitus (T2DM) are aimed not only at glycemic control, but also at reducing cardiovascular risks. The increasing prevalence of the disease and the need for effective treatment options highlight t
Externí odkaz:
https://doaj.org/article/95f6d86f77b4438484e0b9ff432b4ee0
Autor:
I. N. Tyurenkov, D. A. Bakulin, A. V. Smirnov, M. R. Ekova, A. I. Bisinbekova, G. L. Snigur, Yu. I. Velikorodnaya, E. I. Morkovin, D. V. Verkholyak, O. S. Vasilyeva
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 3, Pp 211-227 (2023)
The aim of the work was to evaluate the GABA neuroprotective properties and its structural analogues in old animals after seven months of hyperglycemia.Materials and methods. Diabetes mellitus was modeled in white outbred male rats (12 months old) by
Externí odkaz:
https://doaj.org/article/47992367c688475386ef3d3943d156b4
Autor:
D. V. Kurkin, E. I. Morkovin, D. A. Bakulin, Yu. V. Gorbunova, Yu. A. Kolosov, M. A. Dzhavakhyan, I. E. Makarenko, R. V. Drai, A. V. Zaborovsky, O. V. Shatalova, A. V. Strygin, V. I. Petrov, A. P. Pleten, A. A. Prokopov, T. Yu. Tatarenko-Kozmina
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 3, Pp 193-210 (2023)
The aim of the work is to conduct a review of medications approved by the FDA in 2022.Materials and methods. In searching for the materials to write this review article, bibliographic databases including PubMed, Google Scholar and e-library.ru were u
Externí odkaz:
https://doaj.org/article/8583ca5a7d4043de9ab1b0dd5ccb0858
Autor:
D. V. Kurkin, D. A. Bakulin, E. I. Morkovin, Yu. V. Gorbunova, A. V. Strygin, T. M. Andriashvili, A. A. Sokolova, N. S. Bolokhov, V. E. Pustynnikov, E. A. Fomichev, A. V. Baskova, S. S. Polodyants, A. V. Kasparova
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 2, Pp 104-113 (2023)
The aim of the study was to evaluate a cerebroprotective activity of the sitagliptin and aminoguanidine combination in rats with an acute and chronic cerebral circulation insufficiency, as well as with a traumatic brain injury.Materials and methods.
Externí odkaz:
https://doaj.org/article/91ea2398488e41cb8546951fb823d06b
Autor:
D. V. Kurkin, D. A. Bakulin, E. I. Morkovin, A. V. Strygin, Yu. V. Gorbunova, E. V. Volotova, I. E. Makarenko, V. B. Saparova, R. V. Drai, V. I. Petrov
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 1, Pp 19-47 (2023)
Modern requirements for the treatment of type 2 diabetes mellitus (DM2) include not only achieving a glycemic control, but also reducing the risk of developing cardiovascular complications. Dipeptidyl peptidase 4 (DPP-4) inhibitors are inferior in th
Externí odkaz:
https://doaj.org/article/f0fe50a3b67f4dd0bc0505b700df9935
Autor:
D. V. Kurkin, D. A. Bakulin, E. I. Morkovin, Yu. V. Gorbunova, A. V. Strygin, T. M. Andriashvili, A. A. Sokolova, N. S. Bolokhov, V. E. Pustynnikov, E. A. Fomichev
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 10, Iss 6, Pp 536-548 (2023)
The aim of the work was to determine the antidiabetic effect of a sitagliptin and aminoguanidine combination in rats with experimental diabetes mellitus.Materials and methods. The study was carried out on male Wistar rats and C57BL/KsJ-db/db mice. Ac
Externí odkaz:
https://doaj.org/article/01e777c11d2e46abbb84447ee403e55c
Autor:
V. E. Pustynnikov, S. S. Tsaruk, E. A. Fomichev, E. A. Miloserdova, D. V. Kurkin, D. A. Bakulin, T. M. Andriashvili, A. A. Sokolova, N. V. Atapina, A. K. Brel, Yu. N. Budaeva, I. N. Tyurenkov
Publikováno v:
Сибирский научный медицинский журнал, Vol 42, Iss 5, Pp 52-60 (2022)
Cerebral circulation disorders (CCD) are one of the most common causes of mortality and disability in the population. Improving the microcirculation of brain tissue is one of the main directions in the treatment and prevention of CCD.Aim of the study
Externí odkaz:
https://doaj.org/article/96426b0c2a3a4d62b65af827999d3900
Autor:
D. V. Kurkin, E. E. Abrosimova, D. A. Bakulin, N. S. Kovalev, M. A. Dubrovina, A. V. Borisov, A. V. Strygin, E. I. Morkovin, I. N. Tyurenkov
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 10, Iss 2, Pp 130-153 (2022)
Nitric oxide as a therapeutic approach to the treatment of cardiovascular diseases attracted the attention of researchers at the end of the 19th century. As a vasodilator, nitric oxide may be a unique therapeutic agent for the treatment of hypertensi
Externí odkaz:
https://doaj.org/article/4e3fff5c12294271b8cf6f647278d606
Autor:
D. V. Kurkin, E. I. Morkovin, N. A. Osadchenko, D. A. Bakulin, E. E. Abrosimova, M. A. Dubrovina, N. S. Kovalev, Yu. V. Gorbunova, I. N. Tyurenkov
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 8, Iss 6, Pp 426-435 (2021)
The aim of the study is an experimental confirmation of the use of a new combination of biologically active substances with tonic and antioxidant effects. This combination contains acetylcysteine in its composition to reduce the severity of psychoneu
Externí odkaz:
https://doaj.org/article/1a5992607c6545fe8625adaf05b9f403